De novo CNVs in bipolar affective disorder and schizophrenia

View/ Open
Author
Georgieva, Lyudmila
Rees, Elliott
Moran, Jennifer L.
Chambert, Kimberly D.
Milanova, Vihra
Craddock, Nicholas
Sklar, Pamela
McCarroll, Steven
Holmans, Peter
O'Donovan, Michael C.
Owen, Michael J.
Kirov, George
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1093/hmg/ddu379Metadata
Show full item recordCitation
Georgieva, L., E. Rees, J. L. Moran, K. D. Chambert, V. Milanova, N. Craddock, S. Purcell, et al. 2014. “De novo CNVs in bipolar affective disorder and schizophrenia.” Human Molecular Genetics 23 (24): 6677-6683. doi:10.1093/hmg/ddu379. http://dx.doi.org/10.1093/hmg/ddu379.Abstract
An increased rate of de novo copy number variants (CNVs) has been found in schizophrenia (SZ), autism and developmental delay. An increased rate has also been reported in bipolar affective disorder (BD). Here, in a larger BD sample, we aimed to replicate these findings and compare de novo CNVs between SZ and BD. We used Illumina microarrays to genotype 368 BD probands, 76 SZ probands and all their parents. Copy number variants were called by PennCNV and filtered for frequency (<1%) and size (>10 kb). Putative de novo CNVs were validated with the z-score algorithm, manual inspection of log R ratios (LRR) and qPCR probes. We found 15 de novo CNVs in BD (4.1% rate) and 6 in SZ (7.9% rate). Combining results with previous studies and using a cut-off of >100 kb, the rate of de novo CNVs in BD was intermediate between controls and SZ: 1.5% in controls, 2.2% in BD and 4.3% in SZ. Only the differences between SZ and BD and SZ and controls were significant. The median size of de novo CNVs in BD (448 kb) was also intermediate between SZ (613 kb) and controls (338 kb), but only the comparison between SZ and controls was significant. Only one de novo CNV in BD was in a confirmed SZ locus (16p11.2). Sporadic or early onset cases were not more likely to have de novo CNVs. We conclude that de novo CNVs play a smaller role in BD compared with SZ. Patients with a positive family history can also harbour de novo mutations.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240207/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:13454799
Collections
- HMS Scholarly Articles [17842]
Contact administrator regarding this item (to report mistakes or request changes)